Synthesis and study of psychotropic activity spectrum of 4-aryl-2-benzoylmethylenehydrazono-4-oxobutanoic acids

Abstract

Objective. To study psychotropic activity of 4-aryl-2-benzoylmethylenhidrazono-4-oxobutanoic acids, as well as to determine the relationship between the structure of substances and their biological activity.

Materials and methods. The spectrum of psychotropic activity of 4-aryl-2-benzoylmethylenehydrazono-4-oxobutanoic acids was studied on experimental animals using the open field, black-and-white camera, and extrapolation deliverance tests.

Results. Psychopharmacological effects of various severity and direction were revealed. Two compounds showed anxiogenic properties without deterioration in cognitive potential, one substance displayed a trend to anxiolytic activity. The effect of the certain radicals in the structure of the substances on the studied activities was found.

Conclusions. The obtained links between the structure of original compounds and their psychotropic action can be used in further targeted synthesis and search for new domestic pharmaceutical substances with investigated effects in a series of derivatives of 2,4-dioxobutanoic acids.

Keywords

hydrazons of 2,4-dioxobutanoic acids / psychotropic activity

References

[1] Stein D.J., He Y., Phillips A., Sahakian B.J., Williams J., Patel V. Global mental health and neuroscience: potential synergies. Lancet Psychiatry 2015; 2 (2): 178–85.

[2] Kuznetsov A.S., Sobin F.V., Kozhukhar V.Yu., Pulina N.A. Evaluation of the prospects of searching for biologically active compounds in the series of 4-R-2-hydroxy-4-oxo-2-butenoic acid derivatives. Global Science Capacity 2013; 4: 8–11 (in Russian).

[3] Кузнецов А.С., Собин Ф.В., Кожухарь В.Ю., Пулина Н.А. Оценка перспективности поиска биологически активных соединений в ряду производных 4-R-2-гидрокси-4-оксо-2-бутеновых кислот. Глобальный научный потенциал 2013; 4: 8–11.

[4] Pulina N.A., Kuznetsov A.S., Krasnova A.I., Novikova V.V. Synthesis, antimicrobial activity, and behavioral response effects of N-substituted 4-aryl-2-hydroxy-4-oxobut-2-enoic acid hydrazides and their metal complexes. Pharmaceutical chemistry journal 2019; 53 (3): 220–224 (in Russian).

[5] Пулина Н.А., Кузнецов А.С., Краснова А.И., Новикова В.В. Синтез, антимикробная активность и влияние на поведенческие реакции N-замещенных гидразидов 4-арил-2-гидрокси-4-оксобут-2-еновых кислот и их комплексных производных. Химико-фармацевтический журнал 2019; 53 (3): 30–34.

[6] Pulina N.A., Kuznetsov A.S., Chaschina S.V. Studying of analgesic and antiinflammatory activity of 2,4-dioxobutanoic acid. Permskiy meditsinskiy zhurnal 2020; 37 (4): 115–119 (in Russian).

[7] Пулина Н.А., Кузнецов А.С., Чащина С.В. Изучение анальгетической и противовоспалительной активности гидразинопроизводных 2,4-диоксобутановых кислот. Пермский медицинский журнал 2020; 37 (4); 115–119.

[8] Pulina N.A., Zalesov V.V., Bystritskaya O.A., Rubtsov A.E., Kutkovaya N.V. Synthesis and biological activity of substituted 4-aryl-2-methylenehydrazino-4-oxobut-2-enoic acids and their derivatives. Pharmaceutical chemistry journal 2009; 43 (8): 444–447 (in Russian).

[9] Пулина Н.А., Залесов В.В., Быстрицкая О.А., Рубцов А.Е., Кутковая Н.В. Синтез и биологическая активность замещенных 4-арил-2-метиленгидразино-4-оксобут-2-еновых кислот и их производных. Химико-фармацевтический журнал 2009; 43 (8): 17–20.

[10] Bykov R.A., Balandina S.Y., Komarova O.A., Makhmudov R.R., Sobin F.V., Rubtsov A.E., Trapeznikova N.N., Pulina N.A. Synthesis and biological activity of 4-aryl-2-[(2-oxo-1,2-diphenylethylidene)-hydrazinyl]-4-oxobut-2-enoic-acid amides. Pharmaceutical chemistry journal 2018; 53 (3): 220–224 (in Russian).

[11] Быков Р.А., Трапезникова Н.Н., Баландина С.Ю., Комарова О.А., Махмудов Р.Р., Пулина Н.А., Собин Ф.В., Рубцов А.Е. Синтез и биологическая активность амидов 4-арил-2-[(2-оксо-1,2-дифенилэтилиден)гидразинил]-4-оксобут-2-еновых кислот. Химико-фармацевтический журнал 2018; 52 (5): 33–36.

[12] State Pharmacopoeia of the Russian Federation of the Ministry of Health of the Russian Federation 14th ed. Мoscow 2018; 1: 1814 (in Russian).

[13] Государственная фармакопея Российской Федерации Министерства здравоохранения Российской Федерации XIV изд. М. 2018; 1: 1814.

[14] Guidelines for conducting preclinical studies of drugs. Part One. Pod red. A.N. Mironova. Мoscow: Grif i K 2013; 944 (in Russian).

[15] Руководство по проведению доклинических исследований лекарственных средств. Часть первая. Под ред. А. Н. Миронова. М.: Гриф и К 2013; 944.

RIGHTS & PERMISSIONS

Pulina N.A., Krasnova A.I., Kuznetsov A.S., Naugolnykh E.A.